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Objective: Maintenance of chondrocyte phenotype is a major issue in prevention of degeneration and
repair of articular cartilage. Although the critical pathways in chondrocyte maturation and homeostasis
have been revealed, the in-depth understanding is deﬁcient and novel modifying components and
interaction partners are still likely to be discovered. Our focus in this study was to characterize a novel
cartilage speciﬁc gene that was identiﬁed in mouse limb cartilage during embryonic development.
Methods: Open access bioinformatics tools and databases were used to characterize the gene, predicted
protein and orthologs in vertebrate species. Immunohistochemistry and mRNA expression methodology
were used to study tissue speciﬁc expression. Fracture callus and limb bud micromass culture were
utilized to study the effects of BMP-2 during experimental chondrogenesis. Fusion protein with
C-terminal HA-tag was expressed in Cos7 cells, and the cell lysate was studied for putative glycosami-
noglycan attachment by digestion with chondroitinase ABC and Western blotting.
Results: The predicted molecule is a small, 121 amino acids long type I single-pass transmembrane chon-
droitin sulfate proteoglycan, that contains ER signal peptide, lumenal/extracellular domain with several
threonines/serines prone to O-N-acetylgalactosamine modiﬁcation, and a cytoplasmic tail with a Yin-Yang
site prone to phosphorylation or O-N-acetylglucosamine modiﬁcation. It is highly conserved in mammals
with orthologs in all vertebrate subgroups. Cartilage speciﬁc expression was highest in proliferating and
prehypertrophic zones during development, and in adult articular cartilage, expressionwas restricted to the
uncalciﬁed zone, including chondrocyte clusters in human osteoarthritic cartilage. Studies with experi-
mental chondrogenesismodels demonstrated similar expressionproﬁleswith Sox9, Acan and Col2a1 and up-
regulation by BMP-2. Based on its cartilage speciﬁc expression, themoleculewas named Snorc, (Small NOvel
Rich in Cartilage).
Conclusion: A novel cartilage speciﬁc molecule was identiﬁedwhichmarks the differentiating chondrocytes
and adult articular chondrocytes with possible functions associated with development and maintenance of
chondrocyte phenotype.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.A.-M. Säämänen, Department
Turku, Kiinamyllynkatu 10,
-2-230-1280.
. Säämänen).
s Research Society International. PIntroduction
Long bones develop from the cartilage anlage by endochondral
ossiﬁcation1. At the epiphysis, secondary ossiﬁcation center sepa-
rates the growth plate from developing articular cartilage where
prechondrocytes lining the joint cavity differentiate into articular
chondrocytes2. In both structures, a similar differentiation gradientublished by Elsevier Ltd. All rights reserved.
Fig. 1. Expression proﬁles of genes up-regulated in chondrogenesis. Normalized
expression proﬁles were extracted from oligo chip microarray by Mouse Genome 430
2.0 (Affymetrix) carried out with total RNA extracted from embryonic mouse hind limb
buds (E9.5eE11.5) or knee epiphyses (E12.5eE20.5). Expression proﬁles of genes that
were more than four-fold up-regulated during chondrogenesis after E12.5 with ﬁnal
normalized signal level at E20.5 over 1000 are shown. Genes are presented in the
descending order determined by their expression signal level at E20.5.
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chondrocytes and after terminal differentiation in the hypertrophic
zone are replaced by osteoblasts3,4. Early columnar chondroblasts
are proliferative and actively deposit extracellular matrix rich in
type II collagen and aggrecan. In the prehypertrophic phase,
chondroblasts stop proliferation, mature to chondrocytes and
enlarge. Transition to the hypertrophic phase denotes further
increase in cell volume and change in gene expression, including
synthesis of hypertrophic marker type X collagen.
The development and maintenance of the chondrocyte pheno-
type are regulated by a combination of growth factors, cytokines and
transcription factors, which include members of the transforming
growth factor family (TGF-b), bone morphogenetic proteins (BMPs),
ﬁbroblast growth factors (FGFs) and wingless-type MMTV integra-
tion site family members (Wnts)5,6. The balance of FGF and BMP
signaling pathways determinates the pace of differentiation in each
step of the cascade by regulating proliferation, maturation and
hypertrophy7,8. One of the important regulatory cytokines is BMP-2
that binds to and in limb buds, induces Sox9, a master regulator of
chondrogenesis9e11. Expression of the majority of the cartilage
speciﬁc matrix molecules, including aggrecan, type II, IX and XI
collagens, Comp and several others are targeted by the Sox9 depen-
dent genetic program12,13.
Differential expression of the genes deﬁnes the unique properties
of each tissue, in which the genes that are expressed in a tissue
speciﬁc manner are likely to have a special role. Many of genes
associated with osteoarthritis14 and skeletal disorders15,16 are
reported to have a cartilage-selective expression pattern17,18.
Although the critical pathways in chondrocytematuration have been
revealed, it is likely that many important, unknown, modifying
components or members of signaling pathways are yet to be
discovered. Our focus in this study was to identify novel cartilage
speciﬁc genes that are involved in chondrogenesis and cartilage
maturation. Here we report a novel cartilage speciﬁc molecule Snorc
(Small NOvel Rich in Cartilage), a type I single-pass transmembrane
proteoglycan. It’s highly conserved primary structure, up-regulation
by BMP-2 during chondrogenesis, and tissue distribution proﬁle
associated with differentiating and adult articular chondrocytes
suggest important functions related to the maintenance of the
chondrocyte phenotype.
Materials and methods
In silico analyses
Ensembl and NCBI HomoloGene, RefSeq mRNA and dbEST data-
bases were used to search for full-length homologous transcripts.
Protein precursors of homologs were aligned utilizing M-coffee
multiple sequence alignment software19. A phylogenetic neighbor-
joining tree was constructed using M-coffee and Mega, version
4.020, using pairwise deletion, percent accepted mutation (PAM)
matrix andgammaparameter 1. TheN-terminal cleavedendoplasmic
reticulum (ER) signal peptide characteristic to transmembrane or
secreted proteins was predicted using SignalP 3.021. Following
programs or databases were used to predict different features or
domains: transmembrane sequence, TMHMM 2.022; O-glycosylation
sites, NetOGlyc23 and YinOYang 1.224; serine and threonine residues
prone to phosphorylation, NetPhos25 and ScanProsite; glycosami-
noglycan (GAG) attachment, The Eucaryotic LinearMotif Resource for
Functional Sites (ELM) database.
Experimental animals
C57Bl/6xDBA mice or C57Bl/6 mice were used in immunohisto-
chemical, mRNA expression, and fracture callus studies26,27. Primarychondrocytes or limb bud mesenchymal cells were isolated from
C57B1/6mice. The study plans and use of animalmaterial in research
were approved by the national committee for animal welfare and
animal care was in accordance with their guidelines.
Human tissues
Fetal knee cartilage froma24-week-old embryo (permission17/1/
1990 by the ethical committee of Turku University and Turku
University Central Hospital) and human articular cartilage of
a 75-year-old patient undergoing total knee arthroplasty surgery
(permission 56/2004 by the ethical committee of Jyväskylä
Central Hospital) were collected for RNA isolation. Tissue samples of
the medial femoral condyle were collected for histology from two
75-year-oldmale cadaveric humandonors (permission 1781/32/200/
01 by the National Agency for Medicolegal Affairs in Finland).
Messenger RNA expression studies
Micro dissected mouse limb buds at embryonic days E9.5-E11.5
and developing knee epiphyseal cartilage between E12.5 and E20.5
were pooled for microarray analysis (Fig. 1) from 3 to 18 animals.
Multiple tissues from a 4-day-old mice, knee epiphyses from E12.5
to 20-day-old mice or proximal tibial cartilages from 40-day- to 10-
month-old mice and fracture callus tissue were dissected free of
other tissue. Samples were either stored in RNA later (Ambion) or
frozen in liquid nitrogen and stored at70 C until RNA isolation26.
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unannotated EST transcripts, during mouse limb chondrogenesis
were studied by Mouse Genome 430 2.0 array (Affymetrix). Anal-
ysis was carried out at the Finnish DNAMicroarray Centre in Turku,
Finland. Data was preprocessed and normalized with Affymetrix
GCOS software and mean scaled to 500. Inforsense KDE software
was used to obtain the expression proﬁles of at least four-fold up-
regulated genes after E12.5.
Northern hybridization was performed using a full-length
mouse cDNA clone RIK3110079o15 (German Resource Center for
Genome Research, RZPD) and a mouse 242 bp fragment of Comp
cDNA as hybridization probe templates for random labeling with
a32P-dCTP, and nick translated 28S rRNA for normalization, as
previously described28.
For in situ hybridization, embryos at E16.5 and E18.5 were ﬁxed
in 4% paraformaldehyde, embedded in parafﬁn and serially
sectioned (5 mm). To generate pmSnorc-TOPO, a 381 bp cDNA
fragment was polymerase chain reaction (PCR) ampliﬁed (Table I)
using a full-length cDNA clone BX_518642 (RZPD) as a template,
and cloned into pCR II-TOPO (Invitrogen). Antisense and sense
a35S-dUTP-labeled cRNA probes were synthesized by in vitro tran-
scription with SP6 and T7 RNA polymerases (Promega), respec-
tively. Radioactive in situ hybridization procedures were carried out
as previously described29.
Complementary DNA to total RNA isolated from 24-week-old
fetal or 75-year-old human articular cartilage was transcribed
by M-MLV reverse transcriptase H minus (Promega). To
generate phSNORC-TOPO, PCR fragment covering 366 bp trans-
lated region was ampliﬁed with Phusion DNA-polymerase
(Finnzymes) (Table I), cloned into pCRII-TOPO (Invitrogen)
and sequenced.HA-tag fusion protein construct
Construct pcDNA3.1/SNORC-HA with C-terminal HA-tag was
assembled by cloning of PCR ampliﬁed fragments containing AﬂII
site and ribosomal binding sequence in the 50-end and HA-tag
sequence, stop codon and XbaI site in the 30-end (Table I) into
pcDNA3.1/Hygro(þ) vector (Invitrogen).Table I
Sequences of the primers (50/30) used in generation of the plasmid constructs and
in quantitative real-time PCR (qRT-PCR) analysis
Plasmid constructs
pmSnorc-TOPO
Forward primer CGCGGATCC AGGATGGCATCTTGTCTGG (#)
Reverse primer GCTTCAAGAAGCGGAAAACTT
phSNORC-TOPO (ORF)
Forward primer ATGGCATCCTGTCTGG
Reverse primer TCAGGAGGCAGAAAACTT
pcDNA3.1/SNORC-HA (template phSNORC-TOPO)
Forward primer TTACTTAAG CACC ATGGCATCCTGTCTGGCCCTGCG (&)
Reverse primer TATTATCTAGA TTA TGCGTAATCGGGTACATCGTATGG
GTA GGAGGCAGAAAACTTTCTCAGCGCGAC (x)
qRT-PCR Forward primer Reverse primer
Gene
Actb TTCCTTCTTGGGTATGGAAT GAGCAATGATCTTGATCTTC
Acan CCCGGTACCCTACAGAGACA ACAGTGACCCTGGAACTTGG
Col2a1 ACATGTCAGCCTTTGCTGGC CATGGTCTCTCCAAACCAGA
Comp GTTCAGCGGACCCACCCACG GCATCTCCGATGCCGTCCCG
Sox9 CGACTACGCTGACCATCAGA AGACTGGTTGTTCCCAGTGC
Snorc CTGCTCATCTCTGGGGTCC GATCACGATGGCTGCAATG
Underlined bases are BamHI cleavage site (#), AﬂII cleavage site followed by
50-ribosomal binding site (bold italics) (&), and XbaI site, followed by stop codon
(bold italics) and HA-tag sequence (normal) in reverse order (x). “SNORC sequences
are in bold in (&) and (x)”Expression in Cos7 cells
Cos7 cells (700,000 cells/Ø10 cm Petridish) were transfectedwith
pcDNA3.1/SNORC-HA or pcDNA3.1/Hygro(þ) vector using FuGENE 6
Transfection Reagent (Roche) according to the manufacturer’s
instructions and cultured for 2 days in DMEM,10 % fetal bovine serum
(FBS) (Promocell), 50 U/ml penicillinþ 50 mg/ml streptomycin
(Gibco)30. Cells were extracted with 4 M GuHCl, 50 mM sodium
acetate, pH 5.831, containing 1 Complete protease inhibitor (PI)
(Gibco). Extract was precipitated in 75% ethanol, 2.5% sodium acetate
at 20C, and dissolved in 25mM Tris pH 8.0þ PI for digestion with
chondroitinase ABC, 1 U/ml (SigmaeAldrich) and subjected for
Western blotting30.
Primary antibodies
Two polyclonal antibodies against mouse Snorc were raised in
rabbits by immunization with synthetic peptides 38EPI-
ELPSGEGPLEST52 and 71APEDSTPPARVDQDGG86 comprising amino
acids 38e52 and 71e86 of lumenal/extracellular domain of protein
precursor. Antibodies were produced and puriﬁed using afﬁnity
chromatography (MedProbe, Norway). A mixture of these two
antibodies was used in immunohistochemical studies.
Other primary antibodies weremouse anti-type II collagen (clone
6B3; Chemicon), rabbit anti-mouse type IIA procollagen (MoIIA)32,
rabbit anti-PCNA and goat anti-BMP-2 (Santa Cruz Biotechnology),
and rat anti-HA (epitope 12CA5; Zymed).
Immunohistochemistry and immunoﬂuorescence studies
Paraformalin (4%) ﬁxed and parafﬁn embedded samples were
processed for immunohistochemistry26. Rehydrated 5 mm tissue
sectionswere digestedwith 1 mg/ml hyaluronidase28 (type IV-S from
bovine testes, SigmaeAldrich), or 0.5 U/ml chondroitinase ABC
(SigmaeAldrich) in PBS for 1 h at RT or Ficin (Zymed) for 10 min at
37C. Immunohistochemistry with rabbit polyclonal antibodies and
diaminobenzidine (DAB) detection was performed with Histostain
Broad Spectrum Plus (Invitrogen)32. Immunohistochemistry with
goat polyclonal antibodies was performed with Vectastain Goat ABC
with DAB detection (Vector Laboratories)33. Sections were counter-
stained with hematoxylin (Merck) and mounted in Aquatex (VWR
International). For immunoﬂuorescence, TRITC-labeled goat anti-
mouse IgG (Jackson Laboratories), AlexaFluor 488 goat anti rabbit IgG
(Molecular Probes) and DAPI nucleic acid stain (Vector Laboratories)
were used.
Adenovirus mediated Bmp2 transfer
Messenger RNA samples from mouse fracture callus tissue with
adenovirus mediated Bmp2 gene transfer were obtained from
a previously described study where a standardized fracture was
generated in tibial bone, and RAdBmp2 or RAdLacZwere injected to
the fracture site27. Expression of Snorc and Comp mRNA, and 28S
rRNA was studied in samples collected 5, 7, and 14 days after the
operation by Northern hybridization, as described above.
Limb bud micromass culture
Mouse limb bud cells were isolated from E11.5 embryos as
previously described34, suspended to a density of 2107 cells/ml in
DMEM/F12, 10 % FBS (PAA, Pasching), plated in 10 ml of media
and incubated for 2 h at 37C. Then 500 ml of medium (D-MEM/F12,
10 % FBS, 50 mg/ml ascorbic acid, 10 nM b-glycerophosphate
(SigmaeAldrich)) was carefully added. To study the regulation by
BMP signaling, medium was supplemented with recombinant
J. Heinonen et al. / Osteoarthritis and Cartilage 19 (2011) 1026e1035 1029BMP-2 (200 ng/ml; Peprotech) or Noggin (300 ng/ml, R&D).
Medium was changed every second day. Cultures were terminated
by ﬁxation with 4% paraformalin for 15 min or subjected to RNA
isolation.
Total RNA was extracted with TRIzol (Invitrogen) and cDNAwas
synthesized using revertAid Hminus ﬁrst strand cDNA synthesis kit
(Fermentas). Quantitative PCR was performed with 7500 Real-Time
system using Fast SYBR Green Master Mix (Applied Biosystems).
Primer sequences are listed in Table I. After normalization to b-actin
mRNA, relative expression levels and fold induction of each target
gene were calculated using a comparative CT method [(1/(2DCT))
formula; DCT¼ CTtargetCTreference]35.
Microscopic imaging
In situ hybridization reaction was imaged by virtual microscope
(Dot Slide, Olympus). Zeiss AxioImager M1 microscope was used to
obtain images of sections processed for immunohistochemisty.
Fluorescence detection was performed with Zeiss LSM510 META
laser scanning confocal microscope and Zeiss AxioImager M1
microscope.Statistical analysis
Data analysis for two-group comparisons was performed using
unpaired two-tailed Student’s t test.Fig. 2. Genomic and predicted protein structure of mouse Snorc and compariso
presentation of mouse genomic, and predicted protein structure with ER signal pept
plasmic tail (A). Signal peptide is encoded by exon 1. The ﬁrst 61 N-terminal amino
sentatives of human (Homo), mouse (Mus), bird (Gallus), amphibian (Ambystoma), r
Conserved amino acids comprising at least 50% of all amino acids in vertical column
separating exons 1, 2 and 3. Computationally predicted mammalian O-GalNAc glycosyla
binding). O-GlcNAc glycosylation site (z). Yin-Yang site, according to Prosite consensus p
See Supplementary Fig. 1 for multiple alignments of all found orthologs as available in
C-terminal HA-tag. Coding sequence of human SNORC with C-terminal HA-tag was clon
extracts from cultures transfected with pCDNA3.1/hygro(þ) control vector (lane 1), p
droitinase ABC, 1 U/ml (lane 3). Migrated HA-tag fusion protein was detected with rat a
caused in mobility a shift from a smear to a band.Results
Transcriptome analysis during limb development
Novel chondrogenesis associated genes were searched by
microarray analysis. Cartilage matrix genes were used as common
traits of subsets in cluster analysis. Three criteria were applied in
qualifying unannotated transcripts for further investigation: (1)
abundant expression during chondrogenesis (2) cartilage speciﬁc
expression and (3) conservation during evolution. Riken clone
3110079o15Rik (NM_028473 462 bp), having a similar expression
proﬁle with Acan, Comp and several other cartilage matrix genes,
was identiﬁed (Fig. 1) and selected for further characterization.Computational analyses
Themouse gene contained three exons located on chromosome 1,
cytoband C5. The predicted 121 aa protein precursor (NP_082749.1)
contained cleaved ER signal peptide, putative lumenal/extracellular
(L/EC) domain, transmembrane domain and intracellular domain
[Fig. 2(A)]. Signal peptide and membrane topology prediction
programs strongly preferred the topology of L/EC domain at the
N-terminus and cytoplasmic domain at the C-terminus.
No conserved domains or clear sequence homology with any
annotated protein were observed. Orthologs were detected in 23n of the amino acid structure with other vertebrate orthologs. Schematic
ide, lumenal/extracellular domain, transmembrane domain and C-terminal cyto-
acids of the mature protein are coded by exon 2. Multiple alignments of repre-
eptile (Anolis) and ﬁsh (Danio) amino acid sequences by M-coffee software (B).
are shaded black and similar residues are shaded gray. (;) Indicates residues
tion sites (*). Conserved ELPSGEG peptide also found in aggrecan is indicated (CS
attern predicted phosphorylation site and putative O-GlcNAc glycosylation site (y).
December 2010. (C) Detection of chondroitin sulfate in SNORC fusion protein with
ed into pCDNA3.1/hygro(þ) vector and expressed in Cos7 cells. Western blot of cell
cDNA3.1/SNORC-HA (lane 2), or pcDNA3.1hSNORC-HA after digestion with chon-
nti-HA antibody and visualized by bioluminescence. Chondroitinase ABC digestion
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Conservation of the protein was high between mammalian species
and lower between mammals and other vertebrates, as shown by
the examples from four taxonomic subgroups [Fig. 2(B)]. The
transmembrane domain and cytoplasmic tail were the best-
conserved regions. Cleaved ER signal sequence feature was
conserved throughout vertebrates, suggesting translocation to ER
[Fig. 2(B), Supplementary Fig. 1]. The L/EC domain contained nine
threonines/serines prone to O-N-acetylgalactosamine (O-GalNAc)
modiﬁcation, including GAG binding consensus pattern ELPSGEG.
Digestion of HA-tag fusion protein with chondroitinase ABC caused
a shift from a smear to a band, indicating that it carries chondroitin
sulfate [Fig. 2(C)]. The transmembrane domain was predicted to
locate near the C-terminus. Transmembrane topology and targeting
signal predictions suggested that the core protein is a type I single-
pass transmembrane protein. The cytoplasmic tail contained
a potential cAMP dependent kinase phosphorylation site, which was
also a potential O-N-acetylglucosamine (O-GlcNAc) modiﬁcation site.
Evolutionary relationships of orthologs in 24 species repre-
senting all vertebrate subgroups were studied by using unrooted
neighbor-joining tree analysis. Orthologs of mammals, birds,
reptiles, amphibian and bony ﬁshes were arranged into own groups
according to accepted taxonomy (Fig. 3, Supplementary Fig. 1).Expression of mRNA in mouse cartilage tissues
Snorc and Comp mRNA expression was analyzed in 19 different
mouse tissues at postnatal day 4. Both genes were expressed only in
cartilage samples, including nasal, knee epiphyseal and rib tissues
[Fig. 4(A)]. In situ hybridization of mouse whole embryo sagittal
sections at E16.5 [Fig. 4(BeE)] and E18.5 [Fig. 4(FeI)] demonstrated
a cartilage speciﬁc expression proﬁle of Snorc. In tracheal and nasal
cartilage, mRNA expressionwas seen throughout all chondrocytes at
a similar intensity while in other cartilage tissues undergoing
endochondral ossiﬁcation, intensity was strongest in proliferating
and prehypertrophic stages [Fig. 4(I)]. In knee epiphyseal cartilage,
Snorc and Comp expression was detected from E12.5 onwards, withslammaM
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Fig. 3. Phylogenetic neighbor-joining tree analysis of mature SNORC orthologs.
Taxon speciﬁc clustering was demonstrated in unrooted neighbor-joining tree con-
structed with Mega v4.0. Numbers in internal nodes are supporting values according to
bootstrap analysis (500 replications). Supporting values below 60% were disqualiﬁed.signiﬁcant up-regulation at E16.5 and again at postnatal day 5
[Fig. 4(J)]. Both genes were expressed at least until 10 months of age.Protein distribution
Protein distribution was studied by a mixture of two afﬁnity
puriﬁed rabbit polyclonal antibodies raised against two synthetic
peptides in the L/EC domain. The antibody mixture speciﬁcally
detected the GST fusion protein of the L/EC domain inWestern blots
(data not shown), and had a similar tissue distribution proﬁle with
mRNA as demonstrated by in situ hybridization.
Intracellular staining was observed during embryonic and post-
natal development throughout the differentiating zones, excluding
the superﬁcial two to three cell layers of articular surface and the
hypertrophic zone [Fig. 5(A)]. Highest expressionwas seen, similar to
in situ hybridization data [Fig. 4(H)], in the proliferating and pre-
hypertrophic zones of the developing growth plate.
In the adult mice, intracellular protein was detected in the
uncalciﬁed articular cartilage, while below the tidemark, where
the extracellularmatrix in the calciﬁed cartilage slightly stainedwith
the Snorc antibody, no intracellular staining was seen [Fig. 5(B)].
Trabecular staining in the cartilaginous islands of primary spongiosa
was seen at least up to 6months of age. In adult growth plates, major
staining was observed in the proliferating/prehypertrophic chon-
drocytes. For comparison, tissue distribution proﬁles of BMP-2 and
proliferating cell nuclear antigen PCNA were also studied in adult
mouse articular cartilage and growth plate [Fig. 5(B)]. BMP-2 and
PCNA codistributed with Snorc in uncalciﬁed articular cartilage of
skeletally mature mouse knee, while in growth plate the BMP-2
distribution was not as consistent with Snorc.
Snorc expression in human articular cartilagewas demonstrated
by RT-PCR in 24-week-old fetal epiphyseal cartilage and in articular
cartilage from a 75-year-old donor [Fig. 5(C)]. The ampliﬁed 366 bp
translated region was veriﬁed by sequencing to be the human
ortholog. Interestingly, in the articular cartilage from a 75-year-old
donor, protein was observed only in the chondrocytes in the
superﬁcial part of the uncalciﬁed articular cartilage. In osteoar-
thritic cartilage, Snorc was expressed in the chondrocyte clusters.
Snorc distribution was further studied by immunoﬂuorescence
microscopy in knee articular cartilage and growth plate (Fig. 6). In
a 10-day-oldmouse knee epiphyseal cartilage, confocalmicroscopic
analysis demonstrated intracellular staining, and it appeared as
reticular-like structures throughout the cytoplasm [Fig. 6 (A and B)].
Type II collagen was stained for reference. In the prehypertrophic/
hypertrophic cartilage, chondrocyteswere organized into columnar
clusters where Snorc staining was seen adjacent to the plasma
membrane. Intracellular stainingwas also demonstrated in articular
cartilage, as shown in the 1-month-old mouse tissue [Fig. 6(C)].
In a 6-month-old growth plate [Fig. 6(D)], a cluster of columnar
chondrocytes is shown, where the cells proximal to joint surface
stained for Snorc, but cells closer to the metaphyseal bone did not,
suggesting suppression of synthesis upon progression toward
terminal differentiation.Effect of BMP-2
An in vivo mouse fracture callus model was used to study Snorc
expression during the chondrogenic phase of fracture healing
in vivo and to demonstrate how adenovirus mediated expression of
BMP-2 affected it. Expression of Snorc and Comp mRNA reached
maximum levels in callus tissue at day 7 when also Snorc expres-
sion increased signiﬁcantly in the Bmp2 transfected callus in
comparison to the RadLacZ control [Fig. 7(A)]. Previous studies
indicated increased expression of Sox9 followed by up-regulation of
Fig. 4. Expression of Snorc mRNA in mouse tissues. Expression of Snorc and Comp mRNA in multiple tissues and organs from 4-day-old mouse was analyzed by Northern
hybridization (A). 28S rRNA was used for normalization. In situ hybridization analysis of Snorc in whole embryo sagittal sections at embryonic day E16.5 using 35S-dUTP-labeled
antisense cRNA probe; virtual microscopic image (B). Hybridization with antisense probe at E16.5 of nasal cartilage (C), and hind limb distal femur (D). Sense cRNA probe was used as
a negative control with no apparent hybridization signal as shown for E16.5 distal femur (E). Hybridization with antisense probes at E18.5 of posterior cranial base bones (F), vertebral
anlagen and trachea (G), and hind limb distal femur (H). Hybridization signal appears black in light microscopic images. Bar in panel H equals to 170 mm in panels C and F, and 100 mm
in D, E, G and H. In I, a higher magniﬁcation of a prehypertrophic/hypertrophic region in H is shown. Northern hybridization analysis for relative expression of Snorc and CompmRNA in
mouse knee epiphysis from embryonic day E12.5 to 10 months of age (J). 28S rRNA was used for normalization. N¼ 3 in each group. Values are presented as median range.
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affected by Bmp2.
Mouse limb bud micromass culturewas used to study the effect of
recombinant BMP-2 on Snorc expression. Limb bud micromass
culture is a well established model for mesenchymal differentiation
with phases of mesenchymal cell condensation (days 1e3), chon-
drocyte proliferation (days 4e8), and chondrocyte prehypertrophy
and hypertrophy (days 10e13), followed by matrix mineralization34.
Recombinant BMP-2 up-regulated Snorc expression in mouse limb
bud culture from day 5 to 15, with the highest effect on day 5
[Fig. 7(B)]. Noggin, an inhibitor of Smadsignaling, completely blocked
the expression. Up-regulationwas also observed in Sox9, followed by
Acan and Col2a1 mRNA expression. Immunohistochemical data
suggested earlier deposition of Snorc with advanced onset of chon-
drogenesis, as depicted by deposition of proteoglycans and type IIA
procollagen in BMP-2 supplemented limb buds [Fig. 7(C)].
Discussion
A novel cartilage speciﬁc gene (Snorc) coding for a small type I
single-pass transmembrane proteoglycan was identiﬁed by tran-
scriptome analysis during embryonic mouse limb chondrogenesis.
The genewas up-regulated alongwith several cartilagematrix genes
after E12.5 of embryonic development in mouse knee epiphyseal
cartilage, including genes for cartilage speciﬁc Comp and majorstructural cartilage molecules aggrecan and type II, IX and XI colla-
gens. This up-regulation was associated with the developmental
stagewhen the differentiating chondrocytes actively start depositing
cartilagematrixmolecules tomake functional extracellularmatrix3,4.
The Snorc gene was expressed until at least 10 months of age, with
decreasing intensity by age.
Primary genomic and predicted protein structure and
post-translational modiﬁcation sites were investigated in multiple
databases and programs. The gene contains three exons and was
predicted to code for a small 121 aa protein with ER signal peptide,
a L/EC domain, type I single-pass transmembrane domain and a short
cytoplasmic tail. The predicted protein sequence appeared to be
highly conserved in mammalian species, and less homologous
orthologswere also found in lower vertebrate subgroups. Mouse and
humanproteinswere 86% identical,with thehighest homology in the
signal sequence (96% identical), and transmembrane domain and
cytoplasmic tail (100% identical). Conservation between mammals
and lower vertebrates was smaller but most of the serine/threonine
sites prone to O-glycosylation were highly conserved throughout
species, suggesting that these sites bear important functions in the
post-translationally modiﬁed protein.
The L/EC domain contained several conserved serine or threonine
residues, and interestingly, one of the serines located in the ELPSGEG
peptide. One such peptide and several shorter LPSGE peptide
sequences are found in, e.g., aggrecan at the chondroitin sulfate
Fig. 5. Age-related expression of Snorc protein in knee cartilage. Tissue distribution of Snorc in E18.5 and 5-day-old mouse proximal tibial head (A). Higher magniﬁcations
from superﬁcial (top), central and prehypertrophic/hypertrophic (bottom) regions are presented in the right panels. Tissue distribution of Snorc, BMP-2 and PCNA in 2-month-
old mouse, and Snorc distribution in 6-month-old articular cartilage (top) and growth plate (bottom) in proximal tibial head (B). Expression of human homolog in epiphyseal
and articular cartilage (C). Expression of SNORC mRNA was studied by RT-PCR analysis in human 24-week fetal knee epiphyseal cartilage and human elderly cartilage from
femoral condyle (left panel). Protein distribution is demonstrated by immunohistochemistry in a 75-year-old from nearly normal (left and middle panels) and 75-year-old
osteoarthritic (right panel) articular cartilage (with deep cleft). Cartilage tissues were dissected from the medial condyle of the femur. Higher magniﬁcations are presented in
the insets. Antibody binding was visualized by diaminobenzidine chromogen (brown) and sections were counterstained with hematoxylin. Tidemark is shown by arrowheads
in (B) and (C).
Fig. 6. Tissue distribution of Snorc. Tissue distributionwas studied by confocal microscopy (A) and immunoﬂuorescencemicroscopy (B-D). Proliferating (A) and hypertrophic (B) zones
of 10-day-old knee femoral epiphysis. Articular cartilageof 1-month-old knee femoral epiphysis (C), and growthplate of 6-month-old knee femoral epiphysis (D). Snorcwasdemonstrated
byAlexaFluor488 conjugated antibody (green) and type II collagenby TRITC-conjugated secondaryantibody (red). Nucleiwere stainedwithDAPI (blue). Snorcwas seendistributed in the
cytoplasm (A, C) but also next to the inner plasma membrane (A, arrows) and at the margins of the chondrocyte lacunae, suggesting transition to the plasma membrane and pericellular
space at hypertrophy (B arrows, C). In the chondrocyte clusters of growth plate (D), cells proximal to the articular surface (arrows) stained positive for Snorc.
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Fig. 7. Effect of BMP-2 on Snorc expression. BMP-2 was introduced by Adenovirus mediated gene transfer to the defect sites of tibial fractures by periosteal injection of
recombinant RAdBmp2 (black bars) at the time of operation (¼D0). The control group received an equal amount of RAdLacZ (grey bars). Callus samples were collected at D5, D7 and
D14 after fracture. Relative expression of Snorc and Comp mRNA levels were analyzed by Northern hybridization and normalized to 28S rRNA levels (A). Values are mean 95%
conﬁdence interval of ﬁve individual samples/group. **, P¼ 0.0019, at D7, and *¼ 0.035 two-tailed Student’s t test. Effect of recombinant BMP-2 (100 ng/ml), and Noggin (300 ng/
ml), an inhibitor of BMP signaling pathway, was studied in a limb bud micromass culture model for chondrogenesis. Samples collected after 1, 5, 10 and 15 days of culture were
analyzed by quantitative real-time PCR for relative mRNA expression of Snorc, Sox9, Acan and Col2a1, normalized to Actb (b-actin) (B). Each value represents a mean of three
measurements, pooled from three micromass cultures from one experiment. Experiment was repeated twice with similar effect on gene expression. Histochemical analysis of limb
bud cultures supplemented with BMP-2 (100 ng/ml) was compared with controls (C). Parafﬁn embedded tissue sections from 3, 5 and 10 days of culture were stained with Safranin
O for proteoglycans, type IIA procollagen antibody and Snorc antibody.
J. Heinonen et al. / Osteoarthritis and Cartilage 19 (2011) 1026e1035 1033attachment sites36. C-terminally HA-tagged human SNORC fusion
protein that was expressed in Cos7 cells, was found to contain
chondroitin sulfate, suggesting that it is a proteoglycan. Genes
encoding transmembrane proteoglycan core proteins are less than 10
in vertebrates, including ﬁve full-time proteogloglycans (syndecan-1,
-2, -3, and -4 and melanoma chondroitin sulfate proteoglycan
NG2) and three part-time proteoglycans CD44, betaglycan and
neuropilin-137. Transmembrane proteoglycans are assumed to have
roles as co-receptors in high afﬁnity growth factor receptors or
adhesion receptor like integrins. Also, through their cytoplasmic tails
they participate to the cell signaling and often have a link to actin
cytoskeleton37,38.
The cytoplasmic tail contained a serine/threonine site prone to
phosphorylation and O-GlcNAc glycosylation, called a Yin-yang site
(phosphorylation and glycosylation events are exclusive). Such sites
have been identiﬁed, e.g., in several receptor proteins, and proteins
that are O-glycosylated are also known to be subject to phosphory-
lation. New insights have been proposed to the physiological signif-
icance of O-glycosylation due to recent advances made in the
analytical approaches of O-GlcNAc modiﬁcation and phosphoryla-
tion, suggesting O-glycosylation as a dynamic and essential regula-
tory modiﬁcation39.
In vivo, Snorc was intracellularly distributed, and in the pre-
hypertrophic/hypertrophic zone, the protein was observed marking
the borders of chondrocyte lacunae, suggesting either transit to the
plasma membrane or secretion to the pericellular space. Weak
extracellular staining was observed in prehypertrophic/hypertrophicregions of growth plates and limb bud micromass culture, as well as
in the calciﬁed zone of articular cartilage, with accumulation into the
primary spongiosa at acellular regions that also contain type II
collagen and aggrecan. This matrix staining suggests either shedding
or apoptosis associated release of the protein into the extracellular
matrix. Further studies are required to verify the presence of protein
in the matrix and demonstrate whether this observation has a bio-
logical relevance. Generally, unnecessary matrix molecules are
rapidly removed by proteinases and a coordinated matrix metal-
loproteinase activity is required for the proper endochondral ossiﬁ-
cation during skeletal development40,41.
Snorc expression was high in proliferating and prehypertrophic
cartilage, where parathyroid hormone related peptide (PTHrP)
receptor is also expressed. PTHrP maintains chondrocyte prolifer-
ation together with Indian hedgehog (Ihh) via a negative feedback
loop in the growth plate and prevents transition of prehypertrophic
chondrocytes to hypertrophy42. PTHrP also induces phosphoryla-
tion of Sox9 viaprotein kinase A (PKA),which increases the ability of
Sox9 to induce transcription of COL2A143. Sox9 appears to be
phosphorylated in the prehypertrophic zone44. It is of great interest
whether Snorc, e.g., through its potential Yin-Yang site in the cyto-
plasmic tail has a role in regulating the chondrocyte proliferation or
transition to hypertrophy. In adult mouse articular cartilage, Snorc
codistributed in the uncalciﬁed zone with the cell proliferation
marker PCNA and BMP-2. We have previously demonstrated in
adult mice that Sox9 is similarly restricted to articular chondrocytes
in the uncalciﬁed zone32. In elderly human articular cartilage, the
J. Heinonen et al. / Osteoarthritis and Cartilage 19 (2011) 1026e10351034protein was also expressed in the upper zone of uncalciﬁed carti-
lage, as well as in the chondrocyte clusters of osteoarthritic carti-
lage. Distribution in the uncalciﬁed zone suggests functions related
to maintenance of the articular phenotype.
BMP-2 is one of the major inducers of bone and cartilage devel-
opment. Data from the present and a previous27 study with fracture
callus, and in limb budmicromass culture indicated up-regulation of
Snorc expression by BMP-2 in association with enhanced chondro-
genesis, which was depicted by up-regulation of Sox9, Col2a1 and
Acan. Further, in limb bud culture their expression, including Snorc,
was blocked by Noggin, an inhibitor of BMP signaling. These data
suggest positioning of Snorc downstream of BMP-2. BMP-2 has been
shown to induce Sox9 dependent chondrogenesis10,11. Transcription
factor Sox9 is amaster regulator of chondrogenesis andmaintenance
of differentiated chondrocyte phenotype45. It is reported to control
the genetic program of chondrogenesis by binding directly to a more
than 30 genes coding for extracellular matrix molecules, transcrip-
tion factors and growth factors, and induce their expression during
cartilage differentiation9,12,13. Snorc expression followed the expres-
sion proﬁles of Sox9, Acan and Col2a1 during in vivo chondrogenesis
and in experimental chondrogenesis models, including fracture
callus chondrogenesis and limbbudmicromass culture in the present
study, and in a pellet culture model33 with adult bone marrow iso-
lated mesenchymal stromal cells and mouse embryonic ﬁbroblasts
(unpublished data). Interestingly, the 50UTR of the genomic sequence
contains several bindingmotifs ((A/T)(A/T)CAA(A/T)G)46 for Sox9 and
Sox5/6 (data not shown). Therefore, it is tempting to speculate that
Snorc is additionally a novel target for Sox9 regulation.
To conclude, we have identiﬁed a novel cartilage speciﬁc tran-
script, which is highly conserved in vertebrates. Both mRNA and
protein distribution studies during embryonic development and
aging indicated that the protein is cartilage speciﬁc molecule that
marks the differentiating and articular chondrocytes. Based on
computational and enzymatic digestion studies, the protein has
potential post-translational modiﬁcation sites for O-glycosylation
and carries chondroitin sulfate, suggesting it to be a highly glycosy-
lated transmembrane proteoglycan. Induction by BMP-2 and several
putative Sox9 binding sites in the 50UTR of Snorc gene suggests that it
is a novel target for the BMP-2 regulated chondrogenesis. Further
studies are required to conﬁrm the computationally predicted
features of the protein as well as its regulation and role in mainte-
nance of the chondrocyte phenotype.
Ethics approval of research on humans or animals
In this study we used both animal and human tissues. Ethical
guidelines were followed throughout the study. The animal experi-
ments have been accepted by the local institutional committee of
animal welfare. For collection of human samples “the procedures
followed were in accordance with the ethical standards of the
responsible committee onhuman experimentation (institutional and
national) with the Helsinki Declaration of 1975, as revised in 2000”.
Approvals are stated in the manuscript, including the name and
location of the approving ethics committee(s).
Contributions statement
All of the listed authors have contributed signiﬁcantly in at least
one part of the following: conception and design; data analysis and
interpretation; provision of study material; obtaining funding;
collection and assembly of data; administrative, technical or logistic
support; and drafting the article. All of the listed authors have
participated into critical revisionandﬁnal approval of themanuscript.
Anna-Marja Säämänen takes responsibility for the integrity as
a whole.There were no sponsors involved in the study design, collection,
analysis and interpretation of data; in the writing of the manu-
script; and in the decision to submit the manuscript for publication.
Role of the funding source
This work was supported by Turku University Foundation, Varsinais-
Suomi Regional Fund of Finnish Cultural Foundation, Academy of
Finland (projects 203446 and 205581) and funding from KMEB:
Odense University Hospital. Jussi Heinonen is a graduate student in
National Graduate School of Skeletal Disorders and Biomaterials
(TBGS) and Hanna Taipaleenmäki in Turku Graduate School of
Biomedical Sciences, Turku, Finland.
Conﬂict of interest
There are no competing interests.
Acknowledgments
We thank Merja Lakkisto, Tuula Oivanen, Marja Nykänen and
Mika Savisalo for excellent technical assistance, Dr Kalman Buki for
help in preparation of the fusion protein constructs, and Dr Arto
Pulliainen for sharing the expertise in mock transfections.
Supplementary material
Supplementary data associated with this article can be found in
online version at doi:10.1016/j.joca.2011.04.016.
References
1. Olsen BR, Reginato AM, Wang W. Bone development. Annu
Rev Cell Dev Biol 2000;16:191e220.
2. Wuelling M, Vortkamp A. Transcriptional networks controlling
chondrocyte proliferation and differentiation during endo-
chondral ossiﬁcation. Pediatr Nephrol 2010;25:625e31.
3. Lefebvre V, Smits P. Transcriptional control of chondrocyte fate
and differentiation. Birth Defects Res C Embryo Today 2005;75:
200e12.
4. Goldring MB, Tsuchimochi K, Ijiri K. The control of chondro-
genesis. J Cell Biochem 2006;97:33e44.
5. Watanabe H, de Caestecker MP, Yamada Y. Transcriptional
cross-talk between Smad, ERK1/2, and p38 mitogen-activated
protein kinase pathways regulates transforming growth
factor-beta-induced aggrecan gene expression in chondro-
genic ATDC5 cells. J Biol Chem 2001;276:14466e73.
6. de Crombrugghe B, Lefebvre V, Behringer RR, Bi W,
Murakami S, Huang W. Transcriptional mechanisms of chon-
drocyte differentiation. Matrix Biol 2000;19:389e94.
7. Ornitz DM. FGF signaling in the developing endochondral
skeleton. Cytokine Growth Factor Rev 2005;16:205e13.
8. Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A. Inter-
action of FGF, Ihh/Pthlh, and BMP signaling integrates chon-
drocyte proliferation and hypertrophic differentiation. Dev Cell
2002;3:439e49.
9. Lefebvre V, Dumitriu B, Penzo-Mendez A, Han Y, Pallavi B.
Control of cell fate and differentiation by SRY-related high-
mobility-group box (Sox) transcription factors. Int J Biochem
Cell Biol 2007;39:2195e214.
10. Pan Q, Yu Y, Chen Q, Li C, Wu H, Wan Y, et al. Sox9, a key tran-
scription factor of bone morphogenetic protein-2-induced
chondrogenesis, is activated through BMP pathway and
a CCAAT box in the proximal promoter. J Cell Physiol
2008;217:228e41.
J. Heinonen et al. / Osteoarthritis and Cartilage 19 (2011) 1026e1035 103511. Zhao L, Li G, Zhou GQ. SOX9 directly binds CREB as a novel
synergism with the PKA pathway in BMP-2-induced osteo-
chondrogenic differentiation. J BoneMiner Res 2009;24:826e36.
12. Liu CJ, Zhang Y, Xu K, Parsons D, Alfonso D, Di Cesare PE.
Transcriptional activation of cartilage oligomeric matrix
protein by Sox9, Sox5, and Sox6 transcription factors and CBP/
p300 coactivators. Front Biosci 2007;12:3899e910.
13. Oh CD, Maity SN, Lu JF, Zhang J, Liang S, Coustry F, et al.
Identiﬁcation of SOX9 interaction sites in the genome of
chondrocytes. PLoS One 2010;5:e10113.
14. Reginato AM, Olsen BR. The role of structural genes in the
pathogenesis of osteoarthritic disorders. Arthritis Res 2002;4:
337e45.
15. Superti-Furga A, Unger S. Nosology and classiﬁcation of
genetic skeletal disorders: 2006 revision. Am J Med Genet A
2007;143:1e18.
16. Rimoin DL, Cohn D, Krakow D, Wilcox W, Lachman RS,
Alanay Y. The skeletal dysplasias: clinical-molecular correla-
tions. Ann NY Acad Sci 2007;1117:302e9.
17. Johannessen MK, Skretting G, Ytrehus B, Roed KH. Neonatal
growth cartilage: equine tissue speciﬁc gene expression. Bio-
chem Biophys Res Commun 2007;354:975e80.
18. Funari VA, Day A, Krakow D, Cohn ZA, Chen Z, Nelson SF, et al.
Cartilage-selective genes identiﬁed in genome-scale analysis of
non-cartilage and cartilage gene expression. BMC Genomics
2007;8:165.
19. Wallace IM, O'Sullivan O, Higgins DG, Notredame C. M-Coffee:
combining multiple sequence alignment methods with
T-Coffee. Nucleic Acids Res 2006;34:1692e9.
20. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular
Evolutionary Genetics Analysis (MEGA) software version 4.0.
Mol Biol Evol 2007;24:1596e9.
21. Emanuelsson O, Brunak S, von Heijne G, Nielsen H. Locating
proteins in the cell using TargetP, SignalP and related tools.
Nat Protoc 2007;2:953e71.
22. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting
transmembrane protein topology with a hidden Markov model:
application to complete genomes. J Mol Biol 2001;305:567e80.
23. Julenius K, Molgaard A, Gupta R, Brunak S. Prediction, conserva-
tion analysis, and structural characterization of mammalian
mucin-typeO-glycosylation sites.Glycobiology2005;15:153e64.
24. Gupta R, Brunak S. Prediction of glycosylation across the
human proteome and the correlation to protein function. Pac
Symp Biocomput 2002;310e22.
25. Blom N, Gammeltoft S, Brunak S. Sequence and structure-
based prediction of eukaryotic protein phosphorylation sites.
J Mol Biol 1999;294:1351e62.
26. Säämänen AK, Salminen HJ, Dean PB, De Crombrugghe B,
Vuorio EI, Metsäranta MP. Osteoarthritis-like lesions in
transgenic mice harboring a small deletion mutation in
type II collagen gene. Osteoarthritis Cartilage 2000;8:
248e57.
27. Uusitalo H, Hiltunen A, Ahonen M, Gao TJ, Lefebvre V, Harley V,
et al. Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by
BMP-2 gene transfer during murine fracture healing. J Bone
Miner Res 2001;16:1837e45.
28. Salminen H, Perälä M, Lorenzo P, Saxne T, Heinegård D,
SäämänenAM, et al. Up-regulation of cartilage oligomericmatrix
protein at the onset of articular cartilage degeneration in
a transgenic mouse model of osteoarthritis. Arthritis Rheum
2000;43:1742e8.
29. Takatalo M, Järvinen E, Laitinen S, Thesleff I, Rönnholm R.
Expression of the novel Golgi protein GoPro49 is developmen-
tally regulated during mesenchymal differentiation. Dev Dyn
2008;237:2243e55.30. Sundvall M, Korhonen A, Paatero I, Gaudio E, Melino G,
Croce CM, et al. Isoform-speciﬁc monoubiquitination, endo-
cytosis, and degradation of alternatively spliced ErbB4 iso-
forms. Proc Natl Acad Sci U S A 2008;105:4162e7.
31. Säämänen AM, Tammi M, Kiviranta I, Jurvelin J, Helminen HJ.
Levels of chondroitin-6-sulfate and nonaggregating proteo-
glycans at articular cartilage contact sites in the knees of
young dogs subjected to moderate running exercise. Arthritis
Rheum 1989;32:1282e92.
32. Salminen H, Vuorio E, Säämänen AM. Expression of Sox9 and
type IIA procollagen during attempted repair of articular
cartilage damage in a transgenic mouse model of osteoar-
thritis. Arthritis Rheum 2001;44:947e55.
33. Taipaleenmäki H, Suomi S, Hentunen T, Laitala-Leinonen T,
Säämänen AM. Impact of stromal cell composition on
BMP-induced chondrogenic differentiation of mouse bone
marrow derived mesenchymal cells. Exp Cell Res 2008;314:
2400e10.
34. Mello MA, Tuan RS. High density micromass cultures of
embryonic limb bud mesenchymal cells: an in vitro model of
endochondral skeletal development. In Vitro Cell Dev Biol
Anim 1999;35:262e9.
35. Harkness L, Taipaleenmäki H, Mahmood A, Frandsen U,
Säämänen AM, Kassem M, et al. Isolation and differentiation of
chondrocytic cells derived from human embryonic stem cells
using dlk1/FA1 as a novel surface marker. Stem Cell Rev
2009;5:353e68.
36. Rodriguez E, Roland SK, Plaas A, Roughley PJ. The glycosami-
noglycan attachment regions of human aggrecan. J Biol Chem
2006;281:18444e50.
37. Couchman JR. Transmembrane signaling proteoglycans. Annu
Rev Cell Dev Biol 2010;26:89e114.
38. Choi Y, Chung H, Jung H, Couchman JR, Oh ES. Syndecans as
cell surface receptors: unique structure equates with func-
tional diversity. Matrix Biol 2010;30:93e9.
39. Kohler JJ. Post-translational modiﬁcations: a shift for the
O-GlcNAc paradigm. Nat Chem Biol 2010;6:634e5.
40. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW,
et al. Impaired endochondral ossiﬁcation and angiogenesis in
mice deﬁcient in membrane-type matrix metalloproteinase I.
Proc Natl Acad Sci USA 2000;97:4052e7.
41. Holmbeck K, Bianco P, Chrysovergis K, Yamada S, Birkedal-
Hansen H. MT1-MMP-dependent, apoptotic remodeling of
unmineralized cartilage: a critical process in skeletal growth.
J Cell Biol 2003;163:661e71.
42. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL,
Kronenberg HM, et al. Lethal skeletal dysplasia from targeted
disruption of the parathyroid hormone-related peptide gene.
Genes Dev 1994;8:277e89.
43. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B. The
chondrogenic transcription factor Sox9 is a target of signaling by
the parathyroid hormone-related peptide in the growth plate of
endochondral bones. Proc Natl Acad Sci USA 2001;98:160e5.
44. Huang W, Zhou X, Lefebvre V, de Crombrugghe B. Phosphor-
ylation of SOX9 by cyclic AMP-dependent protein kinase A
enhances SOX9’s ability to transactivate a Col2a1 chondrocyte-
speciﬁc enhancer. Mol Cell Biol 2000;20:4149e58.
45. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de
Crombrugghe B. The transcription factor Sox9 has essential
roles in successive steps of the chondrocyte differentiation
pathway and is required for expression of Sox5 and Sox6.
Genes Dev 2002;16:2813e28.
46. Mertin S, McDowall SG, Harley VR. The DNA-binding speci-
ﬁcity of SOX9 and other SOX proteins. Nucleic Acids Res
1999;27:1359e64.
